Preventing secondary injury in neurocritical care patients is our first priority.

Developing solutions to prevent secondary injury and enhance healing in neurocritical care patients.

Cerevention MindsEye™ is now available to neurosurgeons after successful human use

Mizuho America has secured an exclusive agreement to distribute MindsEye to neurosurgeons in the U.S.

Read the Press Release (pdf)

Our portfolio of innovative neurocritical care solutions includes novel, practical solutions to problems related to secondary injury.

We aspire to provide technologies and interventions to improve outcomes and efficiencies for neurocritical care patients. Our portfolio is built on an expert understanding of desired outcomes and intense focus on unmet needs in neurocritical care.

MindsEye™ Expandable Port
Minimally-invasive access for removal of deep brain lesions
Neurapheresis™ System
Rapid removal of blood from cerebrospinal fluid following subarachnoid hemorrhage
DepiCT™ Neuroimaging Platform
AI-based CT segmentation system

FDA-Cleared for Sale

MindsEye Expandable Port

Developed out of neurosurgeons’ need for deeper access and better visualization. The MindsEye port extends surgical reach while minimizing the impact on surrounding tissue, so you can treat more patients, sooner.

Learn About MindsEye


Caution: Federal (U.S.A.) Law restricts this device to sale by or on the order of a physician.

Currently in Clinical Trials

Neurapheresis CSF Management System

The Neurapheresis Cerebrospinal Fluid (CSF) Management System is designed to be a safe, device-based alternative for treating debilitating and life-threatening diseases that involve foreign bodies in the cerebrospinal fluid.

Learn About Neurapheresis CSF Management System


Caution: Investigational Device. Limited by Federal (U.S.A.) law to investigational use only.

Currently in Development

DepiCT Neuroimaging Platform

DepiCT uses the power of AI to identify anatomic and physiologic features not available via current methods for more informed decision making.

Learn About DepiCT


DepiCT Neuroimaging Platform is currently under development. All subsequent material represents intended use.

Looking to learn more about our neurocritical care technologies? Let’s talk!

Call 651-917-4060 or email